← Leaderboards
Jennifer Marie Spangle
Dana-Farber Cancer Inst
$2,588,221
Attributed
$2,782,792
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $604.1K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,782,792 · 5
By mechanism
R35$1,155,563 · 1
R00$746,975 · 1
R21$608,633 · 2
K99$271,621 · 1
Top collaborators
- Anita H Corbett2 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Alexander H. Stegh$12,620,634
- Kornelia Polyak$28,582,691
- Franziska Michor$16,040,992
- James E Bradner$6,722,003
- Gabriel K. Griffin$806,256
Others in their field
Other Emerging Leaders on “Genetic Transcription”
- Evan Z Macosko · Broad Institute, Inc.$30,129,032
- Sonia Minikel Vallabh · Broad Institute, Inc.$14,507,691
- Tomasz Nowakowski · University Of California, San Francisco$12,105,692
- Chun Jimmie Ye · Feinstein Institute For Medical Research$11,595,683
- Yin Shen · University Of California, San Francisco$10,418,368
- Chongyuan Luo · University Of California Los Angeles$9,805,856
Research focus
Genetic TranscriptionChromatinGene ExpressionMalignant NeoplasmsNucleosomesLysineMethylationHistonesGeneticStructureSignal TransductionCompetenceRegulationMolecularInsightOutputDna Sequence AlterationMethyltransferaseHistone ModificationEpigenetic ProcessCell PhysiologyModificationPhosphorylationTumor
Grant awards (11)
Role of novel histone modifications and variants in transcriptional regulation$384,602
R35 · FY2025 · GM · contact PI
Mapping the origin of HER2 plasticity in breast cancer$219,491
R21 · FY2025 · CA · contact PI
Role of novel histone modifications and variants in transcriptional regulation$385,206
R35 · FY2024 · GM · contact PI
Role of novel histone modifications and variants in transcriptional regulation$385,755
R35 · FY2023 · GM · contact PI
The role of novel oncogenic histone H3 lysine variants in defining a therapeutically actionable epigenetic signature$210,524
R21 · FY2022 · CA · contact PI
The PI3K/AKT Pathway Regulates Histone H3 Modification$248,993
R00 · FY2021 · CA · contact PI
The role of novel oncogenic histone H3 lysine variants in defining a therapeutically actionable epigenetic signature$178,618
R21 · FY2021 · CA · contact PI
The PI3K/AKT Pathway Regulates Histone H3 Modification$248,989
R00 · FY2020 · CA · contact PI
The PI3K/AKT Pathway Regulates Histone H3 Modification$248,993
R00 · FY2019 · CA · contact PI
The PI3K/AKT Pathway Regulates Histone H3 Modification$135,541
K99 · FY2018 · CA · contact PI
The PI3K/AKT Pathway Regulates Histone H3 Modification$136,080
K99 · FY2017 · CA · contact PI